RFE-107

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameRFE-107
Drug Alias Namesomatostatin receptor 2 agonists (RFE Pharma)SSTR2 agonists (RFE Pharma)somatostatin receptor 2 agonists (Somatocor)SSTR2 agonists (Somatocor)SCR-007 +[6] 
ClassificationSmall molecules
Mechanisms of ActionSomatostatin receptor 2 agonistsGrowth hormone release stimulantsGrowth hormone release inhibitors
TargetsSomatostatin receptor 2
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSomatocor Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSomatocor Pharmaceuticals IncRfe Pharma
Active IndicationsN/A
Inactive IndicationsPain

Other Information

ATC CodeN/A
Related LinksN/A